Innate Pharma Income Statement (2017-2025) | IPHA

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Net income details
Profit After Tax (Quarter) -22.98M-76.29M-60.41M-59.28M
Additional items
Shares Outstanding (Weighted Average) (Quarter) 67.82M72.97M87.24M0.02M90.99M81.84M4.35M89.58M109.09M
Shares Outstanding (Diluted Average) (Quarter) 650.60
Shares Outstanding (Quarter) 86.98M94.17M90.99M81.15M86.56M89.58M109.09M